- Home
- ANIX vs PAVS Comparison
ANIX vs PAVS Comparison
Compare ANIX & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- PAVS
- Stock Information
- Founded
- ANIX 1982
- PAVS 2004
- Country
- ANIX United States
- PAVS United States
- Employees
- ANIX N/A
- PAVS N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- PAVS Medicinal Chemicals and Botanical Products
- Sector
- ANIX Health Care
- PAVS Health Care
- Exchange
- ANIX Nasdaq
- PAVS Nasdaq
- Market Cap
- ANIX 108.9M
- PAVS 66.3M
- IPO Year
- ANIX 1987
- PAVS 2019
- Fundamental
- Price
- ANIX $3.20
- PAVS $0.82
- Analyst Decision
- ANIX Strong Buy
- PAVS
- Analyst Count
- ANIX 3
- PAVS 0
- Target Price
- ANIX $9.00
- PAVS N/A
- AVG Volume (30 Days)
- ANIX 104.7K
- PAVS 6.9K
- Earning Date
- ANIX 09-05-2025
- PAVS 08-04-2025
- Dividend Yield
- ANIX N/A
- PAVS N/A
- EPS Growth
- ANIX N/A
- PAVS N/A
- EPS
- ANIX N/A
- PAVS N/A
- Revenue
- ANIX N/A
- PAVS $6,613,273.00
- Revenue This Year
- ANIX N/A
- PAVS N/A
- Revenue Next Year
- ANIX N/A
- PAVS N/A
- P/E Ratio
- ANIX N/A
- PAVS N/A
- Revenue Growth
- ANIX N/A
- PAVS 2.50
- 52 Week Low
- ANIX $2.07
- PAVS $0.32
- 52 Week High
- ANIX $4.20
- PAVS $1.50
- Technical
- Relative Strength Index (RSI)
- ANIX 42.92
- PAVS 38.22
- Support Level
- ANIX $3.21
- PAVS $0.71
- Resistance Level
- ANIX $3.24
- PAVS $1.00
- Average True Range (ATR)
- ANIX 0.15
- PAVS 0.06
- MACD
- ANIX -0.02
- PAVS -0.00
- Stochastic Oscillator
- ANIX 6.98
- PAVS 23.88
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd through its subsidiary, is engaged in the AI-powered entertainment industry, aiming to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It is planning to launch SimTwin application which will allow users to interact with digital versions of people and capture life moments. The company also has a software development agreement with Blueline Studios Inc which is developing 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic.